A Study to Evaluate the Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability of AG-348 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C]AG-348 and Concomitant Single Intravenous Microdose of [13C6]AG-348
Clinical trial NCT03703505 · COMPLETED
Trial details
- NCT number
- NCT03703505
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-24
- Primary completion
- 2018-06-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.